AARD
AARD
US0029421007
Aardvark Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
104.17M EUR
126.05M EUR
82.25M EUR
286.33M EUR
Enterprise Value
29.88M EUR
52.88M EUR
20.15M EUR
239.72M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-2x
--
--
--
Price to Sales
--
--
--
--
Price to Book
1.39x
1.69x
0.95x
2.69x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.4x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-45.02%
-55.07%
-75.08%
-14.98%
ende